Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Telomerase-specific CTL from tumor-bearing patients are spared functional inactivation due to immunologic ignorance

Vonderheide, R.H., Schultze, J.L., Anderson, K.S., Maecker, B., Butler, M.O., von Bergwelt-Baildon, M.S., Wucherpfennig, K.W., Hahn, W.C., Nadler, L.M. Telomerase-specific CTL from tumor-bearing patients are spared functional inactivation due to immunologic ignorance. Annual Meeting of the American Society of Hematology. 2000.


© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.